Search Within

Marinela Capanu

Formats
  1. Journal Article (232)
  2. Meeting Abstract (158)
  3. Correspondence (3)
  4. Miscellaneous (1)
Groups
  1. Biostatistics Service (394)
  2. Center for Pancreatic Cancer Research (394)
  3. Epidemiology and Biostatistics (394)
  4. Department of Medicine (313)
  5. Solid Tumor Oncology Division (310)
  6. Gastrointestinal Oncology Service (280)

More Groups

People
  1. Joanne Chou (167)
  2. David Kelsen (98)
  3. Eileen O'Reilly (97)
  4. Ghassan Abou-Alfa (67)
  5. David Ilson (65)
  6. Yelena Janjigian (61)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (147)
  2. Cancer (18)
  3. Annals of Oncology (15)
  4. Abdominal Radiology (14)
  5. Clinical Cancer Research (12)
  6. Annals of Surgical Oncology (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (152)
  2. Springer (42)
  3. Wiley Blackwell (31)
  4. Oxford University Press (29)
  5. Elsevier Inc. (21)
  6. Lippincott Williams & Wilkins (21)

More Publishers

Results (394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical evaluation of accelerated diffusion-weighted imaging of rectal cancer using a denoising neural network
    Journal Article

    Petkovska, I.; Alus, O.; Rodriguez, L.; El Homsi, M.; Golia Pernicka, J. S.; Fernandes, M. C.; Zheng, J.; Capanu, M.; Otazo, R.
    European Journal of Radiology (2024)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
    Journal Article

    Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Fibrolamellar carcinoma registry: Opportunities and challenges
    Meeting Abstract

    Al Mahmasani, L.; Capanu, M.; Losert, K.; Lowery, M. A.; Hennessy, M.; Ray, M.; Chambers, S.; Yaqubie, A.; Zarski, A.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Suman, S.; Chu, C.; Chou, J. F.; Krein, P. M.; Capanu, M.; Ilson, D. H.; Ku, G. Y.; Janjigian, Y. Y.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety and immunological effects of ablative radiotherapy followed by pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Crane, C. H.; Ziv, E.; Gopalan, A.; Chou, J. F.; Capanu, M.; Reidy, D. L.; Hajj, C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Body mass index (BMI) as a prelude to hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatohepatitis (MASH) risk factors in patients with no identified risk factor for developing hepatocellular carcinoma (HCC)
    Meeting Abstract

    Al Mahmasani, L.; Capanu, M.; Srivastava, A.; Chou, J. F.; Shia, J.; El Dika, I. H.; Yaqubie, A.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save